Company profile
ArsenalBio company profile
ArsenalBio is building a programmable cell therapy company to create highly effective and accessible immune cell therapies to impact outcomes for a much broader number of patients, initially those with cancer. Founded in 2019, ArsenalBio is focused on integrating technologies such as CRISPR-based genome engineering, scaled and high throughput target identification, synthetic biology, and machine learning to advance a new paradigm to discover and develop immune cell therapies. With its programmable and computationally driven approach, ArsenalBio aspires to evolve critical metrics of success for immune cell therapies, including enhanced and broader efficacy, increased patient safety, reduced provider costs and expanded market access.
Business identity
- Website
- https://www.arsenalbio.com
- Contact email
- [email protected]
- Phone number
- +1 650-240-8844
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 251-500 employees
- Founded
- 2019-01-01, Year
Headquarters
- Headquarters
- South San Francisco, California, United States
- Postal code
- 94080
- Country code
- US
- Continent
- North America